Intangible Assets - Nucynta Commercialization Agreement - Table (Details) - USD ($) $ in Thousands |
1 Months Ended | 2 Months Ended | 3 Months Ended | 8 Months Ended | 9 Months Ended | 10 Months Ended | 12 Months Ended | 26 Months Ended | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 05, 2020 |
Dec. 31, 2018 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Nov. 07, 2018 |
Dec. 31, 2019 |
Feb. 29, 2020 |
Feb. 06, 2020 |
Nov. 08, 2018 |
Jan. 31, 2018 |
|
Amortization expense | $ (16,795) | $ (3,688) | $ (43,885) | $ (11,064) | $ (126,340) | ||||||||
Intangible assets, net | 352,699 | $ 352,699 | 352,699 | ||||||||||
Nucynta Products | |||||||||||||
Gross carrying amount | 521,170 | 521,170 | 521,170 | $ 154,089 | |||||||||
Accumulated amortization | (168,471) | (168,471) | (168,471) | (124,586) | |||||||||
Intangible assets, net | 352,699 | 352,699 | 352,699 | 29,503 | |||||||||
Nucynta Commercialization Agreement | Nucynta Products | |||||||||||||
Gross carrying amount | $ 154,089 | 521,170 | 521,170 | 521,170 | 154,089 | $ 515,627 | |||||||
Amortization expense | $ (1,754) | (2,172) | (42,131) | $ (107,662) | (14,752) | ||||||||
Accumulated amortization | (109,834) | (168,471) | (168,471) | (168,471) | (124,586) | ||||||||
Adjustment due to remeasurement of liability | $ (369,581) | ||||||||||||
Additional costs incurred | $ 367,081 | $ 8,043 | |||||||||||
Intangible assets, net | $ 44,255 | $ 352,699 | $ 352,699 | $ 352,699 | $ 29,503 | $ 515,627 |